Chris Cashman, MD, PhD, awarded scholarship for neuropathy research 

Chris Cashman, MD, PhD, was awarded one of two 2026 Clinical Research Training Scholarship (CRTS) to support his neuropathy research. 

The CRTS is a two-year scholarship program that provides funding for emerging experts in neuropathy. The scholarship supports researchers’ efforts to advance treatments, prevention, and even cures for peripheral neuropathy (PN) and is fully funded by the Foundation for Peripheral Neuropathy.   

Cashman is a neurologist at Mass General Brigham and a teacher at Harvard Medical School who studies why the longest nerves in the body are often damaged first. For his research funded through the CRTS, he will study how aging and damage to mitochondria, the parts of cells that make energy, can cause nerve damage. 

Watch Cashman’s video to learn more about his research through the CRTS. 

 Supporting early career researchers  

By supporting researchers like Cashman, the CRTS program is helping move neuropathy research forward and brings us closer to better treatments. Giving early-career scientists the chance to study PN also encourages them to stay in this field, which helps build a strong foundation for future treatments, and one day, even cures.  

Cashman’s two-year $150,000 scholarship is funded solely by the Foundation for Peripheral Neuropathy (FPN) in partnership with the American Brain Foundation. 

 If you’d like to learn more about how you can join us in this initiative, please contact us at [email protected].